Need all Congresses? Press Enter for expanded federal results.

SA 1 to SB 320

Delaware Senate bill in Session 153.

Status: introduced. Latest action: June 4, 2026.

by inserting the following before line 1 and redesignating the sections of this Act accordingly: “Section 1. Amend § 3002G, Title 16 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows: § 3002G. Definitions [For application of this section, see 85 Del. Laws, c. 253, § 23]. For purposes of this chapter: (1) “Health-care practitioner” means an individual licensed under Title 24 as any of the following: a. A physician. b. An advanced practice registered nurse. c. A physician associate. d. A pharmacist. ”. FURTHER AMEND Senate Bill No. 320 by inserting between lines 174 and 175 the following: “ § 2569. Malpractice reporting requirements. (a) A pharmacist practicing under this chapter shall inform the Board in writing of any medical malpractice claim against the pharmacist that has been settled or adjudicated to final judgment (“judgment”). A medical or pharmaceutical insurance carrier who has provided coverage on the malpractice claim shall also inform the Board in writing of the malpractice claim. Notice required to be made under this subsection must be filed with the Board within 30 days of the settlement or judgment. (b) The Board shall refer a notice of medical malpractice made in accordance with subsection (a) of this section to the Division of Professional Regulation to be investigated. The Board must make the referral to the Division of Professional Regulation within 60 days of receiving notice under subsection (a) of this section. ”. FURTHER AMEND Senate Bill No. 320 on line 175 by deleting “ § 2569. ” and inserting in lieu thereof the following: “ § 2570. ”.

Bill ID DE-153-SA-1-TO-SB-320
Session 153
Status introduced
Senate introduced 2026-06-04
Summary

This Amendment adds the following provisions related to pharmacist malpractice to Senate Bill No. 320: (1) Pharmacists practicing under Chapter 25 of Title 24 must inform the Board of Pharmacy of medical malpractice claims that have been settled or adjudicated to final judgment (“judgment”) within 30 days of settlement or judgment. Insurance carriers who have provided coverage on such claims must also notify the Board within that same timeframe. (2) The Board of Pharmacy must, within 60 days of receiving notice of medical malpractice settlement or judgment, refer the case to the Division of Professional Regulation for investigation. This Amendment also adds “pharmacist” to the definition of “health-care practitioner” in § 3002G of Title 16. This addition conforms § 3002G of Title 16 with line 149 of Senate Bill No. 320, which gives pharmacists independent prescriptive authority with respect to opioid antagonists. Author: Senator Pinkney

Sponsor
Pinkney
Official Source Back to Bills
Actions Timeline
Date Event Detail
0000-00-00 Status introduced
2026-06-04 Introduced Bill introduced
2026-06-04 Latest Action Introduced and Placed With Bill
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States